Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10501731 Degradable clostridial toxins

Patent 10501731 was granted and assigned to Allergan, Inc. on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Sanjiv Ghanshani0

Ester Fernandez-Salas0

Joseph Francis0

Kei Roger Aoki0

Lance E. Steward0

Marcella A. Gilmore0

Date of Patent

December 10, 2019

0

Patent Application Number

158455720

Date Filed

December 18, 2017

0

Patent Citations Received

US Patent 11833185 Anti-neurodegenerative therapeutic, method of manufacture, and use

0

US Patent 11248218 Botulinum neurotoxin and its derivatives

US Patent 11286473 Botulinum neurotoxin and its derivatives

0

US Patent 11707510 Nucleic acid-based botulinum neurotoxin for therapeutic use

0

US Patent 11434265 Chimeric neurotoxins

0

Patent Primary Examiner

Iqbal H Chowdhury

0

Patent abstract

The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10501731 Degradable clostridial toxins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool